Location History:
- Paris, FR (1985 - 2002)
- Garches, FR (1999 - 2002)
Company Filing History:
3 out of 870 
1 out of 377 
1 out of 15 Years Active: 1985-2002
Title: The Innovative Contributions of Olivier Danos
Introduction
Olivier Danos is a notable inventor based in Garches, France, with a remarkable tally of six patents to his name. His work significantly impacts the fields of therapeutic products and virology, showcasing his expertise and dedication to scientific advancement.
Latest Patents
One of Danos's most recent patents revolves around a composition for the in vivo production of therapeutic products. This invention focuses on cell compositions for in vivo implantation, designed for the sustained and controlled delivery of therapeutic substances. Another groundbreaking patent involves the molecular cloning and characterization of a novel human retrovirus known as lymphadenopathy-associated virus (LAV), which was among the first retroviruses associated with acquired immune deficiency syndrome (AIDS). This work utilized a cloned LAV complementary DNA (cDNA) to screen a library of recombinant phages constructed from genomic DNA of LAV-infected T lymphocytes. Comprehensive analysis led to the identification of the env coding region, yielding various hydrophilic peptides that correspond to specific amino acids of the LAV envelope glycoprotein. These peptides are crucial for developing diagnostic reagents to detect LAV-specific antibodies and for generating LAV-specific immunological reagents.
Career Highlights
Throughout his career, Olivier Danos has aligned himself with prestigious organizations, including the Institut Pasteur and Aventis Pharma S.A. His work in these institutions has propelled advancements in pharmaceutical research and therapeutic development, underlining his role as a pivotal figure in the scientific community.
Collaborations
Danos's research endeavors have also benefited from collaborations with esteemed colleagues like Philippe Moullier and Jean-Michel Heard. Working alongside such talented scientists has enhanced the depth and reach of his innovations.
Conclusion
In conclusion, Olivier Danos stands out not only for his impressive portfolio of patents but also for his significant contributions to the fields of therapeutic product development and virology. His innovative spirit and collaborative nature continue to inspire others in the scientific community, underscoring the vital role of inventors in advancing healthcare solutions.